Eversept Partners’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-610,231
Closed -$1.39M 89
2025
Q2
$1.39M Buy
610,231
+266,284
+77% +$440K 0.13% 58
2025
Q1
$533K Buy
343,947
+245,052
+248% +$497K 0.05% 56
2024
Q4
$232K Sell
98,895
-307,663
-76% -$1.04M 0.02% 65
2024
Q3
$1.48M Sell
406,558
-204,344
-33% -$815K 0.1% 61
2024
Q2
$2.13M Buy
+610,902
New +$2.64M 0.15% 64
2022
Q2
Sell
-371,540
Closed -$1.55M 82
2022
Q1
$1.55M Sell
371,540
-30,000
-7% -$126K 0.12% 65
2021
Q4
$2.08M Buy
401,540
+3,466
+0.9% +$20.8K 0.13% 79
2021
Q3
$2.61M Sell
398,074
-75,000
-16% -$474K 0.18% 68
2021
Q2
$3.14M Buy
+473,074
New +$2.94M 0.21% 57
2021
Q1
Sell
-154,981
Closed -$1.39M 90
2020
Q4
$1.39M Buy
+154,981
New +$1.65M 0.16% 47
2020
Q3
Sell
-258,360
Closed -$4.14M 52
2020
Q2
$4.14M Buy
258,360
+48,347
+23% +$536K 0.57% 32
2020
Q1
$1.26M Buy
+210,013
New +$1.94M 0.31% 37

Other funds holding AUTL